RemeGen Biosciences
Wei Zhang is a highly experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Director at RemeGen Biosciences since April 2023. Prior to this role, Wei Zhang was a Principal Scientist, Project Manager, and Group Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson from August 2014 to April 2023. Wei Zhang's career also includes positions as Group Leader and Senior Scientist at Siemens, Senior Scientist at AtheroGenics, and Scientist/Senior Scientist at Galileo Laboratories Inc. Beginning as a Postdoctoral Researcher at Wayne State University, Wei Zhang holds a PhD in Organic Chemistry from The University of Texas at Austin and a Bachelor's degree in Chemistry from Fudan University.
This person is not in any teams
RemeGen Biosciences
1 followers
RemeGen is a global biopharmaceutical company, focusing on the discovery, development and commercialization of novel biologics for the treatment of autoimmune, oncology and ophthalmic diseases with significant unmet medical needs. RemeGen Biosciences, a wholly owned subsidiary of RemeGen, is based in South San Francisco, California, the birthplace of biotechnology and in Maryland. Our vision is to create the first-in-class and/or best-in-class biotherapeutics with innovative target discovery strategies, advanced molecule design and protein engineering platforms. Our passion is to serve patients with more effective therapies in a timely manner.